chrisvoncsefalvay/vaers-outcomes huggingface dataset:
pain and swelling where she got the shot; Weakness; Dizziness; pain and swelling where she got the shot; This is a spontaneous report from a contactable other hcp (nurse) reporting for herself. A 99-year-old female patient received bnt162b2 (BNT162B2, Formulation: solution for injection, Lot number: not reported, Expiry date: not provided), dose 2 via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunisation. The patient medical history was not reported. The patient concomitant medication was not reported. On an unspecified date, the patient experienced pain and swelling where she got the shot, weakness and dizziness. Caller stated that last monday afternoon the caller got the second dose of the pfizer covid vaccine and she felt fine until the evening when she had pain and swelling where she got the shot. The next day the caller was so weak she couldn't do anything. Today the dizziness has gone away, and the caller is considerably better. The caller wanted to know how long to expect these symptoms. The clinical outcome of the events pain and swelling where she got the shot and weakness was reported as unknown and dizziness was reported as recovered on an unspecified date.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Numbness and tingling of lips, and jaw numb, noted on her way home from hospital. Checked in with vaccine clinic to report symptoms and be monitored for 30 minutes.Took 50mg Benedryl. Symptoms resolved 12/28/2020.
per MD pt had febrile sz 15MAR95;came to ER 613PM, t102.8
Vaccine was expired at the time of administration, it was past the bud of 10 weeks in the fridge.  Expired on 3/30/22.  Patient is not interested in re-vaccination at this time, may come in a couple months.
severe tension/pain on left side of head; severe tension/pain on left side of head; This is a spontaneous report from a contactable healthcare professional.  A 29-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration right arm on 21Jan2021 as single dose for covid-19 immunization. No medical history was noted.  No allergies to medications, food, or other products.  Concomitant medication included celecoxib (CELEXA). On 24Jan2021, at  08:00, the patient experienced severe tension/pain on left side of head. This was elaborated as behind the eye and above brow bone, radiates to back of neck. The events were non-serious. Prior to vaccination, the patient was not diagnosed with COVID-19.  Since the vaccination, the patient has not been tested for COVID-19. The outcome of severe tension/pain on left side of head  was not recovered.
Information has been received from a nurse concerning a "over 65" year old female who in December 2008, was vaccinated with a dose of PNEUMOVAX (lot n, 659922/1667U) 0.5 ml. In December 2008, the patient experienced pain, swelling and warmth at the injection site. The patient sought medical attention. Subsequently, on an unknown date, the patient recovered. It was reported that the patient was fine at the time of reporting. Additional information has been requested.
left upper extremity DVT 4 weeks later; this was second vaccine; 1st was delivered on  1/13/2021, moderna 012L20A
No additional AE/PQC; the patient received a pediatric dose instead of an adult dose of VAQTA.; This spontaneous report was received from a registered nurse and refers to a patient of unreported age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 12-SEP-2023, the patient was vaccinated with hepatitis a vaccine, inactivated (VAQTA) pre-filled syringe, intramuscular injection, 50/1.0 u/ml, lot #1989614, expiration date: 23-AUG-2024, administered for prophylaxis (strength, and route of administration were not provided). It was reported that the patient received a pediatric dose instead of an adult dose of hepatitis a vaccine, inactivated (VAQTA) (product administered to patient of inappropriate age). It was also reported that the patient would receive "the other half today". No additional adverse event was reported (no adverse event).
This case was reported by a physician via sales representative and described the occurrence of injection site redness in an unknown number of subjects of unspecified ages and gender who were vaccinated with KINRIX (GlaxoSmithKline). On unspecified dates in "late July to August", the subjects received unspecified doses of KINRIX (.5 ml, unknown). At unspecified times after vaccination with KINRIX, the subjects experienced injection site redness, injection site pain, swelling injection site and hot to touch. "Around 10 subjects have received KINRIX vaccine with a reaction of redness, pain, hot to touch and swelling at injection out of 3-400 or more. Some of the subjects have received the vaccine at a County Health department". It was reported the office administers over 200 doses a month and it was possible that ibuprofen was administered to treat symptoms. The physician considered the events were clinically significant (or requiring intervention). The subject was treated with ibuprofen. At the time of reporting the outcome of the events were unspecified.
Began bleeding vaginally, thought it was my normal period however as days went by my flow increased and I was in the ER on 3/24 getting two units of blood. Was given very high doses of progesterone to stop bleeding which did not work and on 4/23 I under went a hysterectomy.
Patient reports pain in administration arm, progressive worsening, limited range of motion over time. Obtained vaccine on 11/30/2016 and states pain has been going on since time of administration, however wife states pain occurred since January. Pain described as 8 out of 10 on pain scale, throbbing, aching down to fingers on a daily basis. Patient obtained tramadol pain medication and Tylenol of which neither seemed to help per wife.
This case was reported by a other health professional and described the occurrence of incorrect storage of drug in a patient who received HAVRIX. On an unknown date, the patient received HAVRIX at an unknown dose. On an unknown date, an unknown time after receiving HAVRIX, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional information received: A few of the vaccines were exposed inappropriate temperatures rendering them unstable. Some of these vaccines were inadvertently administered to children. Patient specific and lot specific information unavailable.
Pt recv vax on 10/27/97; 5 min post vax pt exp wrist pain; on 10/29/97 pt exp muscle pain, numb extremities, burning in legs, joint pain
Certified medical assistant was getting vaccines ready and she accidentally drew up a ProQuad instead of an MMR.  Patient tolerated vaccines well, and parent was informed of what to watch for: Fevers/ febrile seizures/ and rash around the injection site.
Shingles developed after COVID Vaccine.  My  father died of an AAA - he has not a smoker and did not have risk factors.
Pfizer-BioNTech Covid-19 vaccine EUA- Fever at 7am 100.6, 0815 100.8 11am 101.2 treated with Tylenol  fever 1255 100.0 HA started 0900 and some child 1030
Did not sleep for 3 nights after first shot; Headache for 3 days after the first shot; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Did not sleep for 3 nights after first shot) and HEADACHE (Headache for 3 days after the first shot) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Angioma (Patient suffers from Angioma takes Acetaminophen, Tramadol, and Flexeril.). Concomitant products included PARACETAMOL (ACETAMINOPHEN), TRAMADOL and CEFIXIME (FLEXERIL [CEFIXIME]) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INSOMNIA (Did not sleep for 3 nights after first shot) and HEADACHE (Headache for 3 days after the first shot). At the time of the report, INSOMNIA (Did not sleep for 3 nights after first shot) outcome was unknown and HEADACHE (Headache for 3 days after the first shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. treatment medications were not reported.   This case was linked to MOD-2021-318514, MOD-2021-318515.
Left hand is tingling, numb and painful to move hand.  Same symptoms have started on right hand
Fetal demise (in utero death of baby) 11/25/09:  Hospital OB records received for date of service 11/10/09.  Dx:  Stillbirth.  Gravida 5, Para 0 at 25 weeks gestation delivered stillborn infant in the vertex position, gender female.  Nuchal cord x 2.  Apgar scores 0 and 0. Birth weight 448 grams.
got round and swollen, oval; itchy; developed big hives at the site of the injection, about a 3-inch welt; a little sore at the site when she touched it; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a little sore at the site when she touched it), PERIPHERAL SWELLING (got round and swollen, oval), PRURITUS (itchy) and VACCINATION SITE URTICARIA (developed big hives at the site of the injection, about a 3-inch welt) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy, Sulfonamide allergy and Drug allergy (allergic to codeine). Concomitant products included HYDROCHLOROTHIAZIDE, TELMISARTAN and ERGOCALCIFEROL for Allergy, DESLORATADINE (CLARINEX [DESLORATADINE]), MONTELUKAST and TRIAMCINOLONE for Allergy NOS.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced PAIN IN EXTREMITY (a little sore at the site when she touched it). On 01-Feb-2021, the patient experienced PERIPHERAL SWELLING (got round and swollen, oval), PRURITUS (itchy) and VACCINATION SITE URTICARIA (developed big hives at the site of the injection, about a 3-inch welt). The patient was treated with DESLORATADINE (CLARINEX [DESLORATADINE]) at an unspecified dose and frequency; TRIAMCINOLONE at an unspecified dose and frequency and MONTELUKAST at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (a little sore at the site when she touched it), PERIPHERAL SWELLING (got round and swollen, oval), PRURITUS (itchy) and VACCINATION SITE URTICARIA (developed big hives at the site of the injection, about a 3-inch welt) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitants-Ergocalciferol, Triamcinolone Cream   Most recent FOLLOW-UP information incorporated above includes: On 19-Jun-2021: Follow up received on 19-june-2021 and does not contain any significant information
Pt did well until approx 24 hrs post vax; fever 104.2 R, transient lethargy, crying <3 hrs & now consolable eating/urinating OK;
Patient experienced extreme pain in that arm and could not lift it up. She also noticed some swelling.
Swelling of vaccine site resulted in a large disc like lump. Pain and tenderness for over a week. Healed after about 3 1/2 weeks, then left a noticeable indentation in arm where vaccine was given and swelling occured.
Patient received dose from expired vial; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received dose from expired vial) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine, Hypertension, Bipolar disorder and GERD.    On 24-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Sep-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received dose from expired vial). On 24-Sep-2021, EXPIRED PRODUCT ADMINISTERED (Patient received dose from expired vial) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medicines were reported No treatment medicines were reported   Most recent FOLLOW-UP information incorporated above includes: On 30-Sep-2021: Significant follow up appended- Patient demographics, past medical history, suspected dose information, and vaccine facility information updated
Severe ache and intense pain in waves in both my testicles.  This pain started at the same time as the joint aches and muscle soreness about 12 to 16 hours after the shot.  The joint aches and muscle soreness went away after about 36 hours, but the testicle pain is still ongoing now, 49 hours after the shot.  It is much less intense but it is still occurring in waves that last for about 2 to 3 minutes, then it abates to nothing and returns in about 10 or 15 minutes.
FEVER; BODY ACHES; HEADACHE; This spontaneous report received from a patient concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included hypothyroidism, asthma, seasonal allergy, alcoholic, and non-smoker, and other pre-existing medical conditions included patient had no drug abuse or illicit drug usage. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested.  No concomitant medications were reported.  On 08-APR-2021, the subject experienced body aches. On 08-APR-2021, the subject experienced headache. On 09-APR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, and fever on 09-APR-2021, and had not recovered from headache. This report was non-serious.
Pt recvd vax & exp feeling hot, dizzy, nauseated, & flu-like sx;
perioral numbness with HA.  Difficulty swallowing & breathing.  Pt felt it was likely due to the N95 mask.  Given procedural mask and reported improvement of symptoms.  Rapid response contacted. No other intervention
Severe flu symptoms; rash that spreading on both arms.; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 12Apr2021 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. Concomitant medications were not reported. It was unknown that prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14Apr2021 at 02:00, 36 hours after vaccination, the patient experienced severe flu symptoms including fever, sore throat, cough, extreme congestion. On an unknown date in Apr2021, 1 week after vaccination the patient experienced rash that spreading on both arms. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event rash that spreading on both arms and severe flu symptoms was not resolved at the time of report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
patient starting get a red arm from her wrist up.  Her caregiver said she needed to get to the doctor.  Doctor states pt has a skin irritation and gave her an antiobiotic.
Got home about 9:45pm, starting shaking,. Went to bed and her whole body was jumping. Closed her eyes for a while and when she opened her eyes, it was 2 hours later, the jumping stopped. Have no memory between those hours. Since the incident,  she's having some memory issues. Has had shingles twice before, about 20 years ago and three years ago.
dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 021C21A and 027B21A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Regulin) and Contrast media allergy.   On 03-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) had not resolved.            Patient visited the neurologist and underwent a cut scan, no abnormalities were found.  No concomitant medications were reported.  No treatment medications were reported.    This case was linked to MOD-2021-307813 (Patient Link).
Reason for Hospitalization   COVID-19 Pneumonia, Anemia  Hospital Course   This is a pleasant 90-year-old female with a medical history of CAD, hypertension, A. fib on Eliquis, chronic anemia, GERD, tracheostomy who presents to University Hospital with a recent diagnosis of COVID-19 as well as severe anemia.  Patient is also found to have a left lower lobe pneumonia. Pt was treated with levaquin. Pt did not require blood transfusion. No EGD was required per GI. No acute signs of bleeding during stay. Patient is having increased oxygen demands at night and her tracheostomy tube was clogged with thick secretions, started Mucomyst which also helped. PT recommended SNF placement and pt was agreeable. Mucomyst was also sent to pt bedside.  Required up to 10L/min O2 via trach collar during stay.
numbness in body, dizzy, extreme weakness, hard to walk;inflammation in brain & spinal cord;no cure only tx is steroids; transverse myelitis;
Left upper arm sore.  Kept getting worse. Was told it should get better within four weeks.  Lost full movement in arm.  Can only lift approx. 20 degrees up from side, only parallel to ground in front and can't reach behind my back.  Hurts at night when sleeping.  Losing sleep because of it.  Started physical therapy 1/21/2010.  Seeing very limited improvement.
The patient received the vaccine indicated above. Immediately following vaccination the patient states that they began feeling lightheaded and dizzy.
Extreme fatigue, months later atrial tachycardia, sob, diziness, fainting episodes
pt recvd vax 7DEC94 & approx 2-3 days later, devel localized rxn of erythema;seen by MD;treated w/DPH;rxn resolved;
Felt like her throat was closing and was having check tightness in the lower rib area. Her heartrate was 136 and an elevated blood pressure (149/112).  Went to the ER for further care.
Extreme swelling in arm and underarm. Pain radiated down entire arm, into neck and breast. Severe swelling under arm, into breast, and back near shoulder blade. There now appears to be a pocket of fluid which has built up subcutaneously.  Going to doctor for advise and medical treatment options.
Aches, chills, fever about 7 hours after receiving the dose. Lethargic, tired the next day. Same symptoms but  less but less severity than the night before. Slept all day the second day. The third day almost back to normal except for a little listlessness. Took Tylenol the first night and the next morning.
Pt. presented to nurse very anxious about getting the vaccine.  After the vaccine, the pt. stated he is ok and comfortable but still nervous.  Pt. asked for some water.  While getting the water, pt. experienced a dizzy spell and ended up on the floor.  EMT assessed the pt.  Vital signs taken:  BP 132/68, P 80, HR 79, O2 100.  Pt. sustained small laceration on bridge of his nose.  Pt. stated he is ok.  Pt. recovered and left after 15 min. of observation.
On 4/2/07,appox 6 hours after subject given initial dose of Hep-B vaccine, she experienced facial/neck flushing & burning.  Also had rash to face, neck & chest.  Morning of 4/3/07 symptoms progressed with swelling in throat & tongue with difficulty in swallowing.  Additionally, experienced swelling, redness & rash in bilateral hands.  Symptoms continued to progress on 4/3/07 so subject took diphenhydramine and hydroxazine on that date.  On 4/4/07, subject returned to employee health and reported symptoms to us.  She was then sent to Ergent Care & seen by physician.  She additionally experienced bladder spasms & stomach pain. Was told by physician that she was having an allergic reaction to the Hep-B vaccine.  Was instructed to continue diphenhydramine and hydroxazine.  Was given steroid injection at Ergent Care, as well as given Medrol Dose-Pack.
Information has been received from a 53 year old male consumer with no remarkable past medical history and no known allergies who in April 2002 and on 5/12/02 was vaccinated with doses of hepatitis B vaccine recombinant. There was no concomitant medication. After each injection, he developed low grade fever and pain in the back of his neck. He reported that the pain was moving to different parts of his body. The pain continued through the end of May 2002, and started getting worse. He reported this to a physician who told him he was probably having a reaction to hepatitis B vaccine recombinant. It was reported that laboratory studies were done. The pt stated that he has so much pain at the present time (August 2002) that he cannot walk or drive and that he has a constant feeling of malaise with pain. He inquired "when will all this cease" and that "no one has been able to tell him." The consumer mentioned possible legal action. The pt's pain persisted. Follow up info received from the pt's physician indicated that the pt developed muscle aches, an elevated rheumatoid factor and an elevated sedimentation rate. The physician reported that the pt received hepatitis B vaccine recombiant once in May 2002 (reported as 5/12/02 by the pt) and once in June 2002 (reported as April 2002 by the pt). It was reported that after the first shot in the series, the pt reported muscle aches and pains. Upon receipt of the second shot in the series, the pt reported more severe aches and pains. The physician noted that he inherited the pt on 8/1/02. On 8/1/02 the physician took bloodwork. The results of laboratory tests showed an elevated rheumatoid factor and an elevated sedimentation rate. The pt reported to the physician that he was unable to work. No further information was provided. Follow-up info received from the consumer indicated a concern about the treatment of his muscle weakness and arthritic pain. Additional conflicting follow-up info received from the consumer indicated that he received the first dose of hepatitis B vaccine recombinant  back in April of 2002. He reported that "since he got the dose, he has been experiencing some problems with his back and knees." He reported once again that he received the second dose in May 2002. He said that the problems got worse and that the pain in his back and knees increased and that it had gotten to a point where he could hardly walk anymore. He feels that his "bones have tightened up," and has been told that the symptoms resemble arthritic problems. He has also recently been diagnosed with polymyalgia and reported that he was currently receiving prednisone. Upon internal review, polymyalgia was determined to be an other important medical event. Additional info has been requested.